One-year clinical outcomes of patients presenting with st-segment elevation myocardial infarction caused by bifurcation culprit lesions treated with the stentys self-apposing coronary stent: Results from the APPOSITION III study
OBJECTIVE: To investigate outcomes in patients with ST-segment elevation myocardial infarction (STEMI) after treatment with the Stentys self-apposing stent (Stentys SAS; Stentys S.A.) for bifurcation culprit lesions. BACKGROUND: The nitinol, self-expanding Stentys was initially developed as a dedicated bifurcation stent. The stent facilitates a provisional strategy by accommodating its diameter to both the proximal and distal reference diameters and offering an opportunity to "disconnect" the interconnectors, opening the stent toward the side branch. METHODS: The APPOSITION (a post-market registry to assess the Stentys self-expanding coronary stent in acute myocardial infarction) III study was a prospective, multicenter, international, observational study including STEMI patients undergoing primary percutaneous coronary intervention (PCI) with the Stentys SAS. Clinical endpoints were evaluated and stratified by bifurcation vs non-bifurcation culprit lesions. RESULTS: From 965 patients included, a total of 123 (13%) were documented as having a bifurcation lesion. Target-vessel revascularization (TVR) rates were higher in the bifurcation subgroup (16.4% vs 10.0%; P≤.04). Although not statistically significant, other endpoints were numerically higher in the bifurcation subgroup: major adverse cardiac events (MACE; 12.7% vs 8.8%), myocardial infarction (MI; 3.4% vs 1.8%), and definite/probable stent thrombosis (ST; 5.8% vs 3.1%). However, when postdilation was performed, clinical endpoints were similar between bifurcation and non-bifurcation lesions: MACE (8.7% vs 8.4%), MI (1.2% vs 0.7%), and definite/probable ST (3.7% vs 2.4%). CONCLUSIONS: The use of the Stentys SAS was safe and feasible for the treatment of bifurcation lesions in the setting of primary PCI for STEMI treatment with acceptable 1-year cardiovascular event rates, which improved when postdilation was performed.
|Keywords||bifurcation, postdilation, self-apposing stent, self-expanding stent, STEMI, Stentys|
|Journal||Journal of Invasive Cardiology|
Grundeken, M.J, Lu, H, Vos, N.S, IJsselmuiden, A.J.J, van Geuns, R.J.M, Wessely, R, … Koch, K.T. (Karel T.). (2017). One-year clinical outcomes of patients presenting with st-segment elevation myocardial infarction caused by bifurcation culprit lesions treated with the stentys self-apposing coronary stent: Results from the APPOSITION III study. Journal of Invasive Cardiology, 29(8), 253–258. Retrieved from http://hdl.handle.net/1765/100901